Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI

Abstract

A shorter duration of corticosteroids (28 days or less) may be safe for patients with ICPi-AKI. However, the findings may be susceptible to unmeasured confounding and further research from randomized clinical trials is needed.